Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
September 01, 2022 09:45 ET | BioNTech SE
CHMP recommendation based on safety, tolerability, and immunogenicity data from a Phase 2/3 trial of the Omicron BA.1-adapted bivalent vaccineThe Omicron BA.1-adapted bivalent COVID-19 vaccine...
Pfizer und BioNTech erhalten positive CHMP-Empfehlung für Auffrischungsimpfung mit Omikron BA.1-angepasstem bivalenten COVID-19-Impfstoff in der Europäischen Union
September 01, 2022 09:45 ET | BioNTech SE
CHMP-Empfehlung stützt sich auf Daten zur Sicherheit, Verträglichkeit und Immunogenität aus einer Phase-2/3-Studie mit dem Omikron BA.1-angepassten bivalenten ImpfstoffDer an Omikron BA.1 angepasste...
87520785_101152591495741_6497961433500745728_o.jpg
Mycotopia Therapies Partners with Public Policy Specialist PsychedelicsEUROPE to Explore Opportunities in the European Market
May 02, 2022 08:30 ET | Mycotopia Therapies Inc.
MIAMI, May 02, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics,...
Logo 12-21.png
Life Clips Subsidiary Belfrics Group Enters EU; Receives Exchange Operational License in Poland
April 22, 2022 09:41 ET | Life Clips Inc.
AVENTURA, Fla., April 22, 2022 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) today announced its Belfrics Group subsidiary has received its exchange operational license in...
Oceana Analysis Finds U.S. Falls Short on Transparency at Sea
April 12, 2022 09:07 ET | Oceana
Washington, April 12, 2022 (GLOBE NEWSWIRE) -- Oceana released a new analysis today finding that the United States’ requirements for transparency of fishing vessels fall short of other countries’...
Nextnav logo.png
NextNav Showcases APNT Backup to GNSS at European Commission's Joint Research Centre’s Trial
February 01, 2022 13:36 ET | NextNav
SUNNYVALE, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- NextNav (Nasdaq: NN) today announced that it has recently participated in the European Commission’s Joint Research Centre (JRC) alternative...
WHEN.jpg
WHEN Group Signs Letter of Intent to Acquire CrossMobile and Secure Full MVNO License in European Union
January 12, 2022 10:12 ET | World Health Energy Holdings
Acquisition creates a unique, value-added IT platform for B2B/B2C markets, combining GSM, IoT, and AI technologies with cybersecurity solutions NEW YORK, NY, Jan. 12, 2022 (GLOBE NEWSWIRE) -- World...
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of Age in the European Union
November 25, 2021 07:30 ET | BioNTech SE
NEW YORK and MAINZ, Germany, November 25, 2021—Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the Committee for Medicinal Products for Human Use...
Pfizer und BioNTech erhalten positive CHMP-Empfehlung für COMIRNATY® bei Kindern von 5 bis unter 12 Jahren in der Europäischen Union
November 25, 2021 07:30 ET | BioNTech SE
NEW YORK, USA und MAINZ, Deutschland, 25. November 2021—Pfizer Inc. (NYSE: PFE, „Pfizer“) und BioNTech SE (Nasdaq: BNTX, „BioNTech“) gaben heute bekannt, dass der Ausschuss für Humanarzneimittel...
logo.png
HERE launches Intelligent Speed Assistance map for automakers to comply with EU regulation
October 21, 2021 03:00 ET | HERE Technologies
HERE ISA Map provides fresh and accurate speed limit information, with comprehensive coverage across the globe Starting in July 2022, new passenger and commercial vehicles in the EU need to be...